Results 161 to 170 of about 3,038,457 (311)
Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley +1 more source
Intergovernmental Panel on Climate Change, 13th Session, Maldives, 22 & 25-28 September 1997
The Panel approved various draft reports including the draft report of the 12th session. The Panel noted the draft decision paper (introduced by Dr. Watson) on the TAR, and after extensive discussions and amendments, the panel approved the decision ...
World Metrological Organization (WMO) +2 more
core
Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara +10 more
wiley +1 more source
Retraction: Transcription Regulation of HYPK by Heat Shock Factor 1. [PDF]
PLOS One Editors.
europepmc +1 more source
Correction: SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma. [PDF]
Portelinha A +18 more
europepmc +1 more source
Medicine & Science Panel Discussion, October 26 2011, 5:30pmMedicine & Science Panel Discussion, October 26 2011, 5 ...
Knight, John
core
Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau +9 more
wiley +1 more source

